On December 9, 2024, MEDIROM Healthcare Technologies Inc. announced that its subsidiary, MEDIROM MOTHER Labs Inc., has received purchase orders for an aggregate of over 25,000 MOTHER Bracelet units. These orders were placed between July 1, 2024, and October 31, 2024.
The orders include commitments from NFES Technologies Inc. and two other major companies listed on the Tokyo Stock Exchange. This volume of orders surpasses previous fulfillment amounts, indicating growing market penetration for the battery-free smart tracker.
CEO Kouji Eguchi stated that these orders validate the commercialization of MEDIROM's technology and reinforce the MOTHER Bracelet's mission to be revolutionary in the healthcare technology and wellness industries. The device's unique recharge-free feature is a key differentiator for corporate clients.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.